Phase II Study of SU5416 (NSC 696819) for Patients With Progressive Metastatic Renal Cancer Failing Prior Biologic Therapy or 5-Fluorouracil Containing Regimens
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Semaxanib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 30 Jan 2013 New trial record